Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Year: 1992
Type: article
Source: PubMed
Authors: C P Minniti, M Maggi, L J Helman
Institutions: National Cancer Institute, National Institutes of Health
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1878893927
